مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

51
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

51
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

Effect of Curcumin on Beta-Amyloid Plasma Level in Alzheimer Disease: A Systematic Review and Meta-analysis

Pages

  55-59

Abstract

Alzheimer's disease is known as a most common dementia disorder in the world. The famous hypothesis about the cause of this disease is Beta-amyloid (Aβ ) accumulation in the brain. There is a widespread neuroinflammation in the patient's brain, leading to neuronal apoptosis and brain atrophy. Curcumin is a well-known anti-inflammation and anti-oxidant ingredient. It can easily cross the blood-brain barrier. There are controversial results about the effects of Curcumin on Aβ clearance and metabolism in Alzheimer's disease and the elderly. The aim of this Meta-analysis and systematic review was to review the effect of Curcumin on Aβ clearance in clinical studies. We performed a systematic review and Meta-analysis on the three randomized clinical trials (RCTs) and one pilot study that assessed the effect of Curcumin on Aβ plasma level in Alzheimer's disease. For this purpose, we searched PubMed and Scopus databases up to December 2020. Our result showed there was no significant change in serum Aβ level (weighted mean difference [WMD]: 5. 3, 95% CI: 0. 78-9. 97) following Curcumin consumption in patients with Alzheimer's disease. Further clinical trials should be done to evaluate the effects of Curcumin in Aβ level in Alzheimer's disease.

Cites

  • No record.
  • References

    Cite

    APA: Copy

    Mehrabadi, Shima, Alinaghpour, Azam, & ZAHEDI, ELHAM. (2021). Effect of Curcumin on Beta-Amyloid Plasma Level in Alzheimer Disease: A Systematic Review and Meta-analysis. INTERNATIONAL CLINICAL NEUROSCIENCE JOURNAL, 8(2), 55-59. SID. https://sid.ir/paper/975419/en

    Vancouver: Copy

    Mehrabadi Shima, Alinaghpour Azam, ZAHEDI ELHAM. Effect of Curcumin on Beta-Amyloid Plasma Level in Alzheimer Disease: A Systematic Review and Meta-analysis. INTERNATIONAL CLINICAL NEUROSCIENCE JOURNAL[Internet]. 2021;8(2):55-59. Available from: https://sid.ir/paper/975419/en

    IEEE: Copy

    Shima Mehrabadi, Azam Alinaghpour, and ELHAM ZAHEDI, “Effect of Curcumin on Beta-Amyloid Plasma Level in Alzheimer Disease: A Systematic Review and Meta-analysis,” INTERNATIONAL CLINICAL NEUROSCIENCE JOURNAL, vol. 8, no. 2, pp. 55–59, 2021, [Online]. Available: https://sid.ir/paper/975419/en

    Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button